Статус: | Recruiting |
Фаза: | Phase 4 |
Начало: | 13 января 2025 г. |
Окончание: | 31 декабря 2027 г. |
Описание: | Study is to evaluate the efficacy and safety of the drug Ranquilon, 1 mg tablets, at a dosage of 6 mg/day compared to the drug Afobazole, 10 mg tablets, at a dosage of 30 mg/day for the treatment of patients with anxiety disorders due to neurasthenia and adjustment disorders. |
смотреть на ClinicalTrials.gov |
Статус: | Recruiting |
Фаза: | Phase 2 |
Начало: | 14 ноября 2024 г. |
Окончание: | 31 декабря 2026 г. |
Описание: | This study aims to evaluete of tthe efficacy and safety of using different doses of the drug Grammidin with anesthetic, a metered dose topical spray, in the treatment of acute infectious and inflammatory pharyngeal diseases. |
смотреть на ClinicalTrials.gov |